News
The following is a summary of “Assessment of ferritin and hepcidin levels in splenectomised and non-splenectomised ...
Thalassemia and Sickle Cell Anaemia are common genetic disorders, with options for treatment and prevention available.
Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...
2d
Health and Me on MSNHow Widespread Is Thalassemia In India—And What Can Be Done?Thalassemia and sickle cell anaemia are common genetic disorders in India. Early testing, prenatal screening, and improved ...
The proposal, if approved, aims to address the persistent issue of timely blood availability in remote areas, especially for ...
14d
MedPage Today on MSNNearly Half of CDC Birth Defects and Disabilities Staff CutMore than 40% of the 225 scientists and public health workers at the CDC's National Center on Birth Defects and Developmental ...
Norah Awad has lived with beta thalassemia major, a severe blood disorder that has required monthly transfusions since she ...
Editas Medicine struggles with underwhelming data and lacks major partnerships. Find out why EDIT stock faces significant ...
David Liu, Joel Habener, and Alberto Ascherio are among recipients of this year's six Breakthrough Prizes, the "Oscars of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results